Next Article in Journal
Glycaemic Matrix and Segmentation: A New Metabolic Visualisation and Analysis Tool
Previous Article in Journal
Study of Cardio-Metabolic Risk in Overweight and Obese People with Impaired Vitamin D Status
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Postprandial Composite Biomarkers of Low-Grade Inflammation to Evaluate Nutritional Intervention Effects †

by
Suzan Wopereis
*,
Willem J. van den Brink
,
Tim J. van den Broek
,
Wilrike J. Pasman
and
Femke P. M. Hoevenaars
Netherlands Organisation for Applied Scientific Research (TNO), 2333 BE Leiden, The Netherlands
*
Author to whom correspondence should be addressed.
Presented at the 14th European Nutrition Conference FENS 2023, Belgrade, Serbia, 14–17 November 2023.
Proceedings 2023, 91(1), 141; https://doi.org/10.3390/proceedings2023091141
Published: 31 January 2024
(This article belongs to the Proceedings of The 14th European Nutrition Conference FENS 2023)

Abstract

:
Background and objectives: Low-grade inflammation, a hallmark of metabolic disorders, originates in tissues as a consequence of metabolic dysfunction before it progresses to systemic manifestation. The early detection of low-grade inflammation in blood, therefore, is difficult. Here, we set out to develop a postprandial composite biomarker as an early indicator of low-grade inflammation to evaluate the effects of nutritional interventions. Methods: A postprandial composite biomarker was constructed with elastic net regression based on four blood cytokine responses to a mixed-meal challenge test in human reference groups (‘healthy’: 20–29 years, BMI < 25 kg/m2; ‘compromised’: 50–59 years, BMI > 25 kg/m2). The biomarker response was evaluated in three RCT studies with overweight adults and included two studies focusing on energy restriction (ER) and a whole-grain wheat intervention. In one ER study, an extended postprandial composite biomarker was constructed based on a total of twelve inflammatory and vascular markers. Results: A postprandial composite biomarker based on four blood cytokine responses to the mixed-meal challenge test could discriminate between the ‘healthy’ and ‘compromised’ reference groups. The whole-grain wheat intervention showed a significant reduction in the postprandial composite biomarker. No effects of caloric restriction, irrespective of quality of the diet, were observed on the biomarker. The extended postprandial composite biomarker reduced significantly in the persons within the 20% ER intervention group and did not change in the persons in the weight maintenance arm. The reduction correlated with body fat distribution, in particular, the ratio between subcutaneous and internal fat depots. Discussion: Composite biomarkers based on postprandial blood-based cytokine levels are well capable of discriminating low-grade inflammation between ‘compromised’ and ‘healthy’ metabolic phenotypes, which was not possible using fasting blood-based cytokine levels. Although the ability of the four-cytokine-based postprandial composite biomarker of low-grade inflammation to capture the effects of caloric restriction was limited, this biomarker could show the effects of a whole-grain wheat intervention. While whole-grain wheat reduced the secretion of cytokine mediators, an extended version of the composite biomarker indicated that 20% ER only reduced vascular inflammation, suggesting different underlying mechanisms.

Author Contributions

Conceptualization, S.W., F.P.M.H., W.J.P.; methodology, W.J.v.d.B., T.J.v.d.B., formal analysis, T.J.v.d.B.; writing—original draft preparation, S.W.; writing—review and editing, all authors. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The studies included in this evaluation all received medical ethical approval and are registered at ClinicalTrials.gov as NCT01684917, NCT02194504 and NCT02385149.

Informed Consent Statement

In the three studies included in this evaluation Informed consent was obtained from all subjects.

Data Availability Statement

Data described in the manuscript can be made available upon request to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wopereis, S.; van den Brink, W.J.; van den Broek, T.J.; Pasman, W.J.; Hoevenaars, F.P.M. Postprandial Composite Biomarkers of Low-Grade Inflammation to Evaluate Nutritional Intervention Effects. Proceedings 2023, 91, 141. https://doi.org/10.3390/proceedings2023091141

AMA Style

Wopereis S, van den Brink WJ, van den Broek TJ, Pasman WJ, Hoevenaars FPM. Postprandial Composite Biomarkers of Low-Grade Inflammation to Evaluate Nutritional Intervention Effects. Proceedings. 2023; 91(1):141. https://doi.org/10.3390/proceedings2023091141

Chicago/Turabian Style

Wopereis, Suzan, Willem J. van den Brink, Tim J. van den Broek, Wilrike J. Pasman, and Femke P. M. Hoevenaars. 2023. "Postprandial Composite Biomarkers of Low-Grade Inflammation to Evaluate Nutritional Intervention Effects" Proceedings 91, no. 1: 141. https://doi.org/10.3390/proceedings2023091141

APA Style

Wopereis, S., van den Brink, W. J., van den Broek, T. J., Pasman, W. J., & Hoevenaars, F. P. M. (2023). Postprandial Composite Biomarkers of Low-Grade Inflammation to Evaluate Nutritional Intervention Effects. Proceedings, 91(1), 141. https://doi.org/10.3390/proceedings2023091141

Article Metrics

Back to TopTop